Showing results (191-200 of 240) with videos related to

Sort By:
Pageof 24
The American Journal of Psychiatry|March 3, 2007
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE studyMarvin S Swartz, Diana O Perkins, T Scott Stroup, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2026
A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE studyNi A Khin, Reuben H Fan, Tingting Ge, et al.
The American Journal of Psychiatry|December 8, 2006
Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophreniaRobert A Rosenheck, Douglas L Leslie, Jody Sindelar, et al.
The American Journal of Psychiatry|January 4, 2008
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardizationRobert S Kern, Keith H Nuechterlein, Michael F Green, et al.
Archives of General Psychiatry|April 6, 2005
Antipsychotic drug effects on brain morphology in first-episode psychosisJeffrey A Lieberman, Gary D Tollefson, Cecil Charles, et al.
The New England Journal of Medicine|September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophreniaJeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
Schizophrenia Research|December 17, 2010
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization studyRobert S Kern, James M Gold, Dwight Dickinson, et al.
Pageof 24